Voya Investment Management LLC Rigel Pharmaceuticals Inc Transaction History

Voya Investment Management LLC

$79.9 Billion
Q3 2024

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$1.12 - $1.57 $312,649 - $438,267	-279,151 Reduced 13.34%	1,813,868 $2.68 Million
Q4 2023 Feb 14, 2024	BUY	$0.72 - $1.56 $25,864 - $56,039	35,923 Added 1.75%	2,093,019 $3.03 Million
Q3 2023 Nov 14, 2023	BUY	$1.07 - $1.39 $1.24 Million - $1.61 Million	1,157,253 Added 128.61%	2,057,096 $2.22 Million
Q2 2023 Aug 14, 2023	SELL	$1.12 - $1.82 $502,195 - $816,067	-448,389 Reduced 33.26%	899,843 $1.16 Million
Q1 2023 May 15, 2023	SELL	$1.25 - $2.0 $2.06 Million - $3.3 Million	-1,650,259 Reduced 55.04%	1,348,232 $1.78 Million
Q4 2022 Feb 14, 2023	SELL	$0.67 - $11.9 $401,393 - $7.13 Million	-599,095 Reduced 16.65%	2,998,491 $4.5 Million
Q3 2022 Mar 03, 2023	BUY	$1.1 - $12.2 $659,004 - $7.31 Million	599,095 Added 19.98%	3,597,586 $3.96 Million
Q3 2022 Nov 14, 2022	BUY	$1.1 - $12.2 $3.83 Million - $42.5 Million	3,485,036 Added 3096.43%	3,597,586 $4.25 Million
Q2 2022 Aug 15, 2022	BUY	$0.67 - $3.19 $25,608 - $121,924	38,221 Added 51.42%	112,550 $128,000
Q1 2022 May 16, 2022	BUY	$2.22 - $3.45 $14,796 - $22,994	6,665 Added 9.85%	74,329 $222,000
Q4 2021 Feb 14, 2022	SELL	$2.36 - $3.57 $6,022 - $9,110	-2,552 Reduced 3.63%	67,664 $179,000
Q3 2021 Nov 15, 2021	BUY	$3.5 - $4.5 $2,397 - $3,082	685 Added 0.99%	70,216 $254,000
Q2 2021 Aug 16, 2021	SELL	$3.09 - $4.54 $24,305 - $35,711	-7,866 Reduced 10.16%	69,531 $302,000
Q1 2021 May 17, 2021	BUY	$3.35 - $4.93 $10,733 - $15,795	3,204 Added 4.32%	77,397 $265,000
Q4 2020 Feb 16, 2021	BUY	$2.35 - $3.74 $27,276 - $43,410	11,607 Added 18.55%	74,193 $260,000
Q2 2020 Aug 14, 2020	SELL	$1.41 - $2.05 $32,396 - $47,100	-22,976 Reduced 26.85%	62,586 $115,000
Q4 2019 Feb 14, 2020	BUY	$1.6 - $2.43 $16,928 - $25,709	10,580 Added 14.11%	85,562 $183,000
Q2 2019 Aug 14, 2019	BUY	$2.02 - $2.61 $12,754 - $16,479	6,314 Added 9.19%	74,982 $196,000
Q2 2018 Aug 14, 2018	BUY	$2.83 - $4.11 $12,030 - $17,471	4,251 Added 6.6%	68,668 $194,000
Q4 2017 Feb 14, 2018	BUY	$3.23 - $4.3 $34,741 - $46,250	10,756 Added 20.04%	64,417 $250,000
Q3 2017 Nov 14, 2017	BUY	$2.18 - $2.57 $116,980 - $137,908	53,661	53,661 $136,000

Others Institutions Holding RIGL

# of Institutions

Shares Held

334K

Call Options Held

Put Options Held

View Full List

About RIGEL PHARMACEUTICALS INC

Ticker RIGL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 172,836,000
Market Cap $2.96B
Description
Rigel Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs to treat hematologic disorders, cancer, and rare immune diseases. The company offers Tavalisse, an oral spleen tyrosine kinase inhibitor for the treatment of adult patients with chronic immune thrombocytopenia. It also develops Fostamatinib that is ...

More about RIGL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Voya Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Voya Investment Management LLC with notifications on news.

Account